The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency

Pediatric Neurology

Volumn 14, Issue 3, 1996, Pages 236-243

  Pons, Roser ^a   Roig, Manuel ^a   Riudor, Encarnacio ^a   Ribes, Antonia ^b   Briones, Paz ^b   Ortigosa, Luis ^c   Baldellou, Antonio ^d   Gil Gibernau, Juanjo ^a   Olesti, Mariona ^a   Navarro, Carmen ^a   Wanders, Ronald J A ^e  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Dept of Inborn Metabolic Disorders   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d Hospital Miquel Servet   (Spain)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; LONG CHAIN FATTY ACID;

ARTICLE; BRAIN DISEASE; CASE REPORT; CELL ULTRASTRUCTURE; CHILD; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FEMALE; HOMOZYGOSITY; HUMAN; HYDROGENATION; LIVER BIOPSY; MALE; METABOLIC DISORDER; MUSCLE BIOPSY; PRIORITY JOURNAL; RETINOPATHY;

EID: 0029933864     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/0887-8994(96)00021-5     Document Type: Article

References (44)

1. Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. 7th ed. Vol 1. New York: McGraw-Hill, 1995:1501-53.
2. Kunaw WH, Dommes V, Schulz H. Beta-oxidation of fatty acids in mitochondria, peroxisomes and bacteria. A century of continued progress. Lipid Res (in press).
3. Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria, I. Purification and properties of very-long-chain acyl-coenzymes A dehydrogenase. J Biol Chem 1992;267:1027-33.
4. Uchida Y, Izai K, Orii T, Hashimoto T. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl CoA hydratase-3-hydroxyacyl-CoA dehydrogenase-3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 1992;267:1034-41.
5. Stanley CA. Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, Tade K, eds. Inborn metabolic diseases. Berlin: Springer-Verlag, 1990:395-410.
6. Hale DE, Bennett MJ. Fatty acid oxidation disorders: A new class of metabolic disease. J Pediatr 1992;121:1-11.
7. Hale DE, Thorpe C, Braat K, Wright JH, Coates PM, Glasgow AM. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 1989;25:199A.
8. Wanders RJA, Duran M, Ijlst L, et al. Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase. Lancet 1989;1:52-3.
9. Riudor E, Ribes A, Boronat M, Sabado C, Dominguez C, Ballabriga A. A new case of C6-C14 dicarboxylic aciduria with favourable evolution. J Inherited Metab Dis 1986;11(suppl 2):297-99.
10. Ribes A, Riudor E, Navarro C, Boronat M, Marti M, Hale DE. Fatal outcome in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherited Metab Dis 1992;15:278-9.
11. Glasgow AM, Engel AG, Bier DM, et al. Hypoglucemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium-chain triglyceride diet. Pediatr Res 1983;17:319-26.
12. Engel AG. Carnitine deficiency syndromes and lipid storage myopathy. In: Engel AG, Banker BQ, eds. Myology: Basic and clinical. New York: McGraw-Hill, 1986:1663-96.
13. Hale DE, Thorpe C, Braat K, et al. The long-chain 3-hydroxyacyt-CoA dehydrogenase deficiency. In: Tanaka K, Coates PM, eds. Fatty acid oxidation: Clinical, biochemical, and molecular aspects. New York: Alan R Liss, 1990:503-10.
14. Poll-The BT, Bonnefont JP, Ogier H, et al. Familial hypoketotic hypoglucaemia associated with peripheral neuropathy, pigmentary retinopathy and C6-C14 hydroxydicarboxylic aciduria. A new defect in fatty acid oxidation. J Inherited Metab Dis 1986;11:183-5.
15. Wanders RJA, Ijlst L. Long-chain 3-hydroxyacyl-CoA dehydrogenase in leukocytes and chorionic villus fibroblasts: Potential for pre- and postnatal diagnosis. J Inherited Metab Dis 1992;15:356-8.
16. Kelley RI, Morton DH. 3-Hydroxyoctanoic aciduria: Identification of a new organic acid in the urine of a patient with non-ketotic hypoglycemia. Clin Chim Acta 1988;175:19-26.
17. Pollit RJ, Losty H, Westwood A. 3-Hydroxydicarboxylic aciduria: A distinctive type of intermittent dicarboxylic aciduria of possible diagnostic significance. J Inherited Metab Dis 1989;10:266-9.
18. Pollit RJ. Clinical and biochemical presentations in 20 cases of hydroxydicarboxylic aciduria. In: Tanaka K, Coates PM, eds. Fatty acid oxidation: Clinical, biochemical, and molecular aspects. New York: Alan R Liss, 1990:495-502.
19. Wanders RJA, Ijlst L, Gennip AH, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Identification of a new inborn error of mitochondrial fatty acid beta-oxidation. J Inherited Metab Dis 1990;13:311-4.
20. Duran M, Wanders RJA, Jager JP, et al. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with sudden infant death: Protective effect of medium-chain triglyceride treatment. Eur J Pediatr 1991;150:190-5.
21. Hangenfeldt L, Dobeln U, Holme E, et al. 3-Hydroxydicarboxylic aciduria, a fatty acid oxidation defect with severe prognosis. J Pediatr 1990;116:388-9.
22. Venizelos N, Ijlst L, Wanders RJA, Hangenfeldt L. Beta oxidation enzymes in fibroblasts from patients with 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 1994;36:111-4.
23. Rocchiccioli F, Wanders RJA, Aubourg P, et al. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: A cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990;28:657-62.
24. Dionisi-Vici C, Burlina AB, Bertini E, et al. Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Pediatr 1991;118:744-6.
25. Pryzrembel H, Jakobs C, Ijlst L, Klerk, Wanders RJA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherited Metab Dis 1991;14:674-80.
26. Jackson S, Barlett K, Land J, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 1991;29:406-11.
27. Bertini E, Dionisi-Vici C, Garavaglia B, et al. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Eur J Pediatr 1992;151:121-6.
28. Moore R, Glasgow JFT, Bingham MA, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency diagnosis, plasma carnitine fractions and management in a further patient. Eur J Pediatr 1993;152: 433-6.
29. Sewell AC, Bender SW, Wirth S, Munterfering H, Ijlst L, Wanders RJA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A severe fatty acid oxidation disorder. Eur J Pediatr 1994;153:745-50.
30. Treem WR, Rinaldo P, Hale DE, et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994;19:339-45.
31. Tein I, Donner EJ, Hale DE, Murphy EG. Clinical and neurophysiologic response of myopathy and neuropathy in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency to oral prednisone. Pediatr Neurol 1995;12:68-76.
32. Barth PG, Scholte HR, Berden JA, et al. An X-linked mitochondrial disease affecting cardiac muscle, and neutrophil leukocytes. J Neurol Sci 1983;62:327-55.
33. Wanders RJA, Ijlst L, Poggi F, et al. Trifunctional protein deficiency: A new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun 1992;188:1139-45.
34. Ijlst L, Wanders RJA, Ushikubo S, Kamijo T, Hashimoto T. Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Identification of the major disease-causing mutation in the alfa subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta 1994;1215:347-50.
35. Emery JL, Howat AJ, Variend S, Vawter GF. Investigation of inborn errors of metabolism in unexpected infant deaths. Lancet 1988;i: 29-31.
36. Wilcken B, Leung K, Hammond J, Kamath R, Leonard JV. Pregnancy and fetal long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Lancet 1993;341:407-8.
37. Sims HF, Brackett JC, Powell CK, et al. The molecular basis of pediatric long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995;92:841-5.
38. Marshall J, Heckenlively JR. Pathologic findings and putative mechanism of retinitis pigmentosa. In: Heckenlively JR, ed. Retinitis pigmentosa. Philadelphia: Lippincott, 1988:37-67.
39. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 1989;83:927-36.
40. Fryburg JS, Pelegano JP, Bennett MJ, Bebbin EM. Long-chain 3-hydroxyacyl-CoA dehydrogenase (L-CHAD) deficiency in a patient with Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 1994;52: 97-102.
41. Ruvalcaba RHA, Myhre S, Smith DW. Sotos syndrome with intestinal polyposis and pigmentary changes of the genitalia. Clin Genet 1980;18:413-6.
42. Berkley R, Budden SS, Buist NRM. Dominantly inherited megalencephaly, muscle weakness and myoliposis: A carnitine-deficient myopathy within the spectrum of the Ruvalcaba-Myhre-Smith syndrome. J Pediatr 1993;123:70-5.
43. Kamijo T, Wanders RJA, Saudubray J, Aoyama T, Komiyama A, Hashimoto T. Mitochondrial trifunctional protein deficiency. J Clin Invest 1994;93:1740-7.
44. Jackson S, Kler RS, Barlett K, et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1993;90:1219-25.